Masimo (MASI) Liabilities and Shareholders Equity (2010 - 2026)
Masimo (MASI) recorded quarterly Liabilities and Shareholders Equity of $1.6 billion in Q2 2026, down 3.31% quarter-over-quarter from $1.7 billion in Q1 2026, and down 28.36% on a YoY basis from $2.3 billion in Q2 2025.
Masimo (MASI) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Masimo's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $1.6 billion for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity fell 28.36% year-over-year to $1.6 billion; the TTM figure through Apr 2026 stood at $7.6 billion (down 30.63% YoY), while the FY2026 annual figure was $1.7 billion, down 35.3% from the prior year.
- Liabilities and Shareholders Equity was $1.6 billion for Q2 2026 at Masimo, down from $1.7 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.2 billion in Q4 2022 to a low of $1.6 billion in Q2 2026.
- Historically, Liabilities and Shareholders Equity has averaged $2.6 billion across 5 years, with a median of $2.9 billion in 2024.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity jumped 76.08% in 2022, then slumped 41.14% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.2 billion in 2022, then fell by 5.27% to $3.0 billion in 2023, then dropped by 13.67% to $2.6 billion in 2024, then plunged by 30.78% to $1.8 billion in 2025, then slipped by 9.62% to $1.6 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $1.6 billion (Q2 2026), $1.7 billion (Q1 2026), and $1.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 6.63 Bn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 37.13 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 1.64 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1.64 Bn |
| Jan 3, 2026 | 1.70 Bn |
| Sep 27, 2025 | 1.82 Bn |
| Jun 28, 2025 | 2.40 Bn |
| Mar 29, 2025 | 2.29 Bn |
| Dec 28, 2024 | 2.63 Bn |
| Sep 28, 2024 | 3.09 Bn |
| Jun 29, 2024 | 2.89 Bn |
| Mar 30, 2024 | 2.96 Bn |
| Dec 30, 2023 | 3.04 Bn |
| Sep 30, 2023 | 3.00 Bn |
| Jul 1, 2023 | 3.01 Bn |
| Apr 1, 2023 | 3.12 Bn |
| Dec 31, 2022 | 3.21 Bn |
| Oct 1, 2022 | 3.06 Bn |
| Jul 2, 2022 | 2.96 Bn |
| Apr 2, 2022 | 1.91 Bn |
| Jan 1, 2022 | 1.89 Bn |
| Oct 2, 2021 | 1.77 Bn |
| Jul 3, 2021 | 1.68 Bn |